Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-07-28FDA Approved: DIVALPROEX SODIUM — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for divalproex sodium submitted by BluePoint Laboratories, associated with an existing ANDA.
-
FDA approval · 2023-07-28FDA Approved: LAMOTRIGINE — Supplemental Application (Dr. Reddys Laboratories Inc.)
FDA approved a supplemental application for lamotrigine from Dr. Reddy's Laboratories Inc., under the ANDA process.
-
FDA approval · 2023-07-17FDA Approved: ARIPIPRAZOLE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for aripiprazole from Ascend Laboratories, allowing a generic version to be marketed.
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder [NA]
Clinical trial update for accelerated theta burst stimulation in inpatients with bipolar disorder has been terminated; results posted in 202…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients [Phase 2]
Phase 2 trial assessing JNJ-18038683 for cognition and depressive symptoms in stable bipolar disorder; study completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-06-29FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application for ARIPIPRAZOLE, granting approval of the generic ARIPIPRAZOLE product.
-
CLINICAL_TRIALS research · 2023-06-22Clinical Trial Update: Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness [Phase 4]
Phase 4 trial update on novel pharmacotherapy approaches for nicotine dependence in smokers with serious mental illness, completed with post…
-
FDA approval · 2023-06-15FDA Approved: ARIPIPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for aripiprazole from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2023-06-12FDA Approved: ARIPIPRAZOLE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for ARIPIPRAZOLE submitted by Unichem Pharmaceuticals (USA), Inc., enabling the generic product to b…
-
FDA approval · 2023-06-09FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves a generic Lurasidone hydrochloride tablet (ANDA 212124) from Macleods Pharmaceuticals Limited. The product is indicated for sch…
-
FDA approval · 2023-06-08FDA Approved: LAMOTRIGINE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Lamotrigine from Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2023-06-07FDA Approved: OLANZAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approves a supplemental application for olanzapine from Macleods Pharmaceuticals Limited, granting approval of a generic version of the …
-
FDA approval · 2023-06-07FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Quetiapine Fumarate by Macleods Pharmaceuticals Limited under ANDA203359.
-
FDA approval · 2023-06-07FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for ziprasidone hydrochloride filed by Macleods Pharmaceuticals Limited under an ANDA, indicating a …
-
FDA approval · 2023-06-07FDA Approved: OLANZAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Olanzapine submitted by Macleods Pharmaceuticals Limited (ANDA 203044). This is a regulatory upd…
-
FDA approval · 2023-06-07FDA Approved: QUETIAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for a generic quetiapine product from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: tDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients [Phase 2]
Phase 2 clinical trial evaluating transcranial direct current stimulation (tDCS) as an add-on treatment for resistant major depression in un…
-
FDA approval · 2023-06-05FDA Approved: QUETIAPINE — Supplemental Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare Inc.'s supplemental application for quetiapine (ANDA 202152), granting approval of a generic quetiapine p…
-
FDA approval · 2023-05-30FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approves a supplemental application for quetiapine fumarate submitted by Unichem Pharmaceuticals (USA), Inc.
-
FDA label_change · 2023-05-19FDA Approved: LAMOTRIGINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for lamotrigine submitted by Actavis Pharma, Inc. The action pertains to updating or amending th…
-
FDA approval · 2023-05-11FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for quetiapine fumarate submitted by BluePoint Laboratories. This action approves a modification to …
-
FDA approval · 2023-05-11FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for quetiapine fumarate filed by Sun Pharmaceutical Industries.
-
FDA approval · 2023-05-11FDA Approved: QUETIAPINE EXTENDED RELEASE — Supplemental Application (ACI Healthcare USA, Inc.)
FDA approves a supplemental application for a generic Quetiapine Extended Release product from ACI Healthcare USA, expanding access to the e…
-
FDA approval · 2023-05-11FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for quetiapine fumarate from Aurobindo Pharma Limited, enabling generic production under an Abbrevia…
-
FDA approval · 2023-05-11FDA Approved: QUETIAPINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA granted a supplemental approval for Quetiapine (generic) from Ascend Laboratories, LLC, approving an additional application for this…